Eric Lim

Thoracic surgeon, statistician, clinical trialist. 🇬🇧 Into research, post grad education and patient advocacy.

[virtual Grand Rounds @vGrandRounds]

Thank you to Dr John Heymach for an excellent presentation today on HER2 Alterations in Lung Cancer: An Update!

🎥 Watch: https://t.co/dNma9n92HQ
🎧 Listen: https://t.co/urEfCgYo3B
🔔 Subscribe: https://t.co/8O0Lnhv2fa 

@ekslim @AstraZeneca @Medtronic

[virtual Grand Rounds @vGrandRounds]

Thank you Prof. Yasuhiro Tsutani for an excellent presentation on Adjunctive Systemic Therapies in Early-Stage (Stage I) Lung Cancer!

🎥 Watch: https://t.co/IKU6DUl3f6
🎧 Listen: https://t.co/9ymL43sAlV
🔔 Subscribe: https://t.co/8O0Lnhv2fa

@ekslim @AstraZeneca @Medtronic

[virtual Grand Rounds @vGrandRounds]

Join us Fri 17 April, 8:00 AM BST for a session with Professor Patrick Forde (@FordePatrick), Professor of Oncology at Johns Hopkins University.

🎙�� Expanding the Checkpoint Inhibitor Landscape in Lung Cancer

🎓 1 CME credit
🔗register here: https://t.co/sCX4OzSJPI

[virtual Grand Rounds @vGrandRounds]

Prof Suresh Senan gave an excellent presentation today on Integrating Radiotherapy into the Management of Resectable Lung Cancer!

🎥 Watch:
https://t.co/Gri4BnNd1m
🎧 Listen: https://t.co/V5latykK4k
🔔 Subscribe: https://t.co/8O0Lnhv2fa

@ekslim @AstraZeneca @Medtronic

[Eric Lim @ekslim]

Surgical access doesn't just affect complications, it determines survival! A paradigm shift thanks to an international effort of trialists from Europe to China, published this week in The Lancet.

https://t.co/OzrFogxlAH

[Eric Lim @ekslim]

@spotgamma @StevePalmroyal @spotgamma pls can you let me know what’s happened to support? there are numerous reports from your product subscribers that sections don’t work and we are not hearing back from support? really frustrating…

[BTOG @BTOGORG]

Learning how to succeed (and fail) in trials with @ekslim. Honest reflections and invaluable lessons for investigators. #BTOG26

[virtual Grand Rounds @vGrandRounds]

Thank you to Professor Julie Wu for an excellent presentation today on Harnessing Large Language Models to Advance Screening!

🎥 Watch: https://t.co/eDjkUGUVkc
🎧 Listen: https://t.co/1BlRcq4n3O
🔔 Subscribe: https://t.co/8O0Lnhv2fa

@ekslim @AstraZeneca @Medtronic

[virtual Grand Rounds @vGrandRounds]

Can large language models transform cancer screening and early detection?

Join us Fri 27 Feb, 8:00 AM GMT, for an exciting session with Professor Julie Wu (U.S. Department of Veterans Affairs & University of California, Los Angeles).

🎙️ Harnessing Large Language Models to Advance Screening
🎓 1 CME credit (Royal College of Physicians)
🔗 https://t.co/ltAviNpkQa

#GrandRounds #AIinHealthcare #CancerScreening #CME

[Statistics Course @StatsCourse]

Measured the same patients twice? Use paired tests to unlock clearer results, greater power, and publishable conclusions.

Get your research published with https://t.co/iT40UkLdOY 📖

[virtual Grand Rounds @vGrandRounds]

Thank you to Professor Long Jiang (@DylanDrJiang) for an excellent presentation today on Refining Strategies for Screening High-Risk Populations!

🎥 Watch: https://t.co/nL4Hk3mLOG
🎧 Listen: https://t.co/XyzoHYNGLf
🔔 Subscribe: https://t.co/CCvs8jTyCE

@ekslim @AstraZeneca @Medtronic

[virtual Grand Rounds @vGrandRounds]

How can we better identify and protect those at highest risk of #LungCancer?

Join us this Friday, 20 Feb at 8:00 AM GMT, for an exciting Grand Round with Professor Long Jiang (@DylanDrJiang), Deputy Chief of Staff & Consultant Surgeon at Shanghai Chest Hospital.

🎙️ Refining Strategies for Screening High-Risk Populations
💻 Free registration: https://t.co/ltAviNpkQa
📌 Live Q&A included – don’t miss it!

#ThoracicOncology #CME #MedicalEducation #EarlyDetection #GrandRounds

[Eric Lim @ekslim]

@5_utr @GavittWoodard @RajaFlores thank you, sounds like you are an objective reviewer with equipoise! 👍🏼

[Eric Lim @ekslim]

@5_utr @GavittWoodard @RajaFlores Because journal editors and reviewers are not very good at picking up what you both did in an instance / or are simply turning a blind eye to it.

[Eric Lim @ekslim]

@5_utr @GavittWoodard @RajaFlores I think you both are picking up on your own accord what people would say and do (that makes no sense) just to criticize work that they don’t like the result of - it’s both amusing, tragic and deeply concerning all at the same time.

[virtual Grand Rounds @vGrandRounds]

Thank you to Professor Neal Navani (@LungConsultant) for an excellent presentation today on Determinants of Lung Cancer Risk in Never-Smokers!

🎥 Watch: https://t.co/nL4Hk3mLOG
🎧 Listen: https://t.co/DiWSBE1ttO
🔔 Subscribe: https://t.co/CCvs8jTyCE

@ekslim @AstraZeneca @Medtronic

[Statistics Course @StatsCourse]

Ever wondered when to use a risk ratio vs an odds ratio?

Master the right tests for your data and get your research published at https://t.co/8jYHEmjuSg 📊

[virtual Grand Rounds @vGrandRounds]

What drives lung cancer risk in never-smokers?

Join us this Friday (13 Feb) at 8:00 AM GMT for an exciting session with Professor Neal Navani (@LungConsultant), Professor of Respiratory Medicine at @uclh.

🎙️Topic: Determinants of Lung Cancer Risk in Never-Smokers

Register here: https://t.co/ltAviNpkQa

🎓 Earn 1 CME credit | 💬 Live Q&A

#LungCancer #ThoracicOncology #CME #MedicalEducation

[virtual Grand Rounds @vGrandRounds]

Thank you to Dr Anant Patel (@veggielungdoc) for an excellent presentation today on Lung Cancer Prevention: Progress and Challenges in Smoking Cessation!

🎥 Watch: https://t.co/M61BYZ8d3B
🎧 Listen:https://t.co/ArRIuFSdy0
🔔 Subscribe: https://t.co/CCvs8jTyCE

@ekslim @AstraZeneca @Medtronic

[Statistics Course @StatsCourse]

Wonder drug X for weight loss doubles the risk of pancreatitis. Should we stop prescribing it immediately?

Further your learning with https://t.co/iT40UkLdOY ✏️